| Date | Time | Source | Headline | Symbol | Company |
| 12/08/2019 | 20:12 | Edgar (US Regulatory) | Unknown (sec Staff) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 08/08/2019 | 17:03 | Edgar (US Regulatory) | Amended Application for Qualification of Trust Indentures (t-3/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 19/07/2019 | 18:51 | Edgar (US Regulatory) | Application for Qualification of Trust Indentures (t-3) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 14/02/2017 | 19:00 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 14/02/2017 | 15:22 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 08/02/2017 | 21:35 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 31/01/2017 | 20:43 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 12/12/2016 | 15:42 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 09/12/2016 | 21:07 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 09/12/2016 | 11:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 05/12/2016 | 11:02 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 01/12/2016 | 22:45 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 01/12/2016 | 22:26 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 30/11/2016 | 20:32 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 22:08 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:26 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:23 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:23 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 21:22 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 29/11/2016 | 17:10 | GlobeNewswire Inc. | Aegerion Pharmaceuticals, Inc. and QLT Inc. Complete Merger Transaction; QLT to Change Name to Novelion Therapeutics Inc. | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 17/11/2016 | 21:15 | GlobeNewswire Inc. | Aegerion Pharmaceuticals’ JUXTAPID® (lomitapide) Capsules for the Treatment of Homozygous Familial Hypercholesterolemia (H... | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 16/11/2016 | 11:01 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 07/11/2016 | 22:40 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 04/11/2016 | 21:34 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 04/11/2016 | 20:03 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |
| 03/11/2016 | 21:21 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:AEGR | Aegerion Pharmaceuticals, Inc. |